Insulin-like Growth Factor (IGF)-I, IGF-II and IGF Type I Receptor (IGFR-I) Expression in Prostatic Cancer

Anticancer Research

Volumn 23, Issue 5 A, 2003, Pages 3825-3835

  Cardillo, Maria Rosaria ^a   Monti, Salvatore ^a   Di Silverio, Franco ^a   Gentile, Vincenzo ^a   Sciarra, Francesco ^a   Toscano, Vincenzo ^b  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

IGF I; IGF II; IGFR I genes prostate cancer

Indexed keywords

LIGAND; PARAFFIN; SOMATOMEDIN B; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE EPITHELIUM; PROSTATIC INTRAEPITHELIAL NEOPLASIA; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STROMA; TISSUE SPECIFICITY;

AGED; AGED, 80 AND OVER; EPITHELIAL CELLS; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INSULIN-LIKE GROWTH FACTOR I; INSULIN-LIKE GROWTH FACTOR II; MALE; MIDDLE AGED; NEOPLASM STAGING; PROSTATIC NEOPLASMS; RECEPTOR, IGF TYPE 1; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; STROMAL CELLS;

EID: 0345392848     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Khandwala HM, McCutcheon IE, Flyvbjerg A and Friend KE: The effects of insulin-like growth factors on tumorigenesis and neoplastic growth. Endocr Rev 21: 215-244, 2000.
2. Werner H and Le Roith D: The insulin-like growth factor-I receptor signaling pathways are important for tumorigenesis and inhibition of apoptosis. Crit Rev Oncog 8: 71-92, 1997.
3. Le Roith D, Parrizas M and Blakesley VA: The insulin-like growth factor-I receptor and apoptosis. Implications for the aging progress. Endocrine 7: 103-5, 1997.
4. Grimberg A and Cohen P: Role of insulin growth factors and their binding proteins in growth control and carcinogenesis. J Cell Physiol 183: 1-9, 2000.
5. Yu H and Rohan T: Role of the insulin-like growth factor family in cancer development and progression. J Int Cancer Inst 92: 1472-1489, 2000.
6. Jones JI and Clemmons DR: Insulin-like growth factors and their binding proteins: biological actions. Endocr Rev 16: 3-34, 1995.
7. Cohen P: Serum insulin-like growth factor-I levels and prostate cancer risk-interpreting the evidence. J Natl Cancer Inst 90: 876-879, 1998.
8. Chan, JM, Stampfer MJ, Giovannucci E, Gann PH, MA J, Wilkinson P, Hennekens CH and Pollak M: Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study. Science 279: 563-566, 1998.
9. Tennant MK, Thrasher B, Twomey PA, Drivdahl RH, Birnbaum RS and Plymate SR: Protein and mRNA for IGFR-I is decreased and IGF-II is increased in human prostate carcinoma compared to benign prostate epithelium. J Clin Endocrinol and Metabol 81: 774-3781, 1996.
10. Figueroa JA, De Raad S, Speights VO and Rinehart JJ: Gene expression of insulin-like growth factors and receptors in neoplastic prostate tissue: correlation with clinico-pathological parameters. Cancer Investigation 19: 28-34, 2001.
11. Mita K, Nakahara M and Usui T: Expression of the insulin-like growth factor system and cancer progression in hormone-treated prostate cancer patients. Int J Urol 7: 321-9, 2000.
12. Kimura G, Kasuya J, Giannini S, Honda Y, Mohan S, Kawachi M, Akimoto M and Fujita-Yamaguchi: Insulin-like growth factor (IGF) system components in human prostatic cancer cell-lines: LNCaP, DU145 and PC-3 cells. Int J Urol 3: 39-46, 1996.
13. Di Giovanni J, Kiguchi K, Frijhoff A, Wilker E, Bol DK, Beltran L, Moats S, Ramirez A, Torcano J and Conti C: Deregulated expression of insulin-like growth factor I in prostate epithelium leads to neoplasia in transgenic mice. PNAS 97: 3455-3460, 2000.
14. Dong G, Rajah R, Vu T, Hoffman AR, Ronsenfeld RG, Roberts CT, Peehl DM and Cohen P: Decreased expression of Wilms' tumor gene WT-1 and elevated expression of insulin growth factor-II (IGF-II) and type 1 IGF receptor genes in prostatic stromal cells from patients with benign prostatic hyperplasia. J Clin Endocrinol Metab 82: 2198-2203, 1997
15. Bonnet P, Reiter E, Bruyninx M, Sente B, Dombrowicz D, de Leval J, Closset J and Hennen G: Benign prostatic hyperplasia and normal prostate aging: differences in type I and II 5 alpha reductase and steroid hormone receptor messenger ribonucleic acid (mRNA) levels, but not in insulin-like growth factor mRNA levels. J Clin Endocrinol Metab 77: 1203-1208, 1993.
16. Monti S, Di Silverio F, Iraci R, Martini C, Zanzara S, Falasco P, Poggi M, Stigliano A, Sciarpa F and Toscano V: Regional variations of insulin-like growth factor I (IGF-I), IGF-II, and receptor type I in benign prostatic hyperplasia tissue and their correlation with intraprostatic androgens. J Clin Endocrinol Metab 86: 1700-1706, 2001.
17. Boudon C, Rodier G, Lechevallier E, Mottet N, Barenton B and Sultan C: Secretion of insulin-like growth factors and their binding proteins by human normal and hyperplastic prostatic cells in primary culture. J Clin Endocrinol Metab 81: 612-617, 1996.
18. Cohen P, Peehl DM, Baker B, Liu F, Hintz RL and Rosenfeld R: Insulin-like growth factor axis abnormalities in prostate stromal cells from patients with benign prostatic hyperplasia. J Clin Endocrinol Metab 79: 1410-1415, 1994.
19. Gleason DF: Histologic grading of prostate cancer. A perspective. Human Pathol 23: 273-279, 1992.
20. TNM Atlas: Illustrated Guide to TNM/pTNM Classification of Malignant Tumours. Fourth Edition. New York, Springer Erlag, pp272-280, 1997.
21. Cardillo MR, Petrangeli E, Perracchio L, Salvatori L, Ravenna L and Di Silverio F: Transforming growth factor-β expression in prostate neoplasia. Anal Quant Cytol Histol 22: 1-10, 2000.
22. Sandberg-Nordqvist AC, Stahlbom PA, Reinecke M, Collins VP, von Holst H and Sara V: Characterization of insulin-like growth factor 1 in human primary brain tumors. Cancer Res 53: 2475-2478, 1993.
23. Le Bouc Y, Noguiez P, Sondermeijer P, Dreyer D and Girard F: A new 5′-non-coding region for human placental insulin-like growth factor II mRNA expression. FEBS Lett 28, 222: 181-185, 1987.
24. Ullrich A, Gray A, Tam AW, Yang-Feng T, Tsubokawa M, Collins C, Henzel W, Le Bon T, Kathuria S and Chen E: Insulin-like growth factor I receptor primary structure: comparison with insulin receptor suggests structural determinants that define functional specificity. EMBO J 5: 2503-2512, 1986.
25. Chomczynski P and Sacchi N: Single step methods of RNA extraction by acid-guanidium-thyocyanate-phenol-chloroform extraction. Anal Biochem 162: 156-159, 1987.
26. Roy RN, Cecutti A, Gerulath AH, Steinberg WM and Bhavnani BR: Endometrial transcripts of human insulin-like growth factors arise by differential promoter usage. Mol Cell Endocrinol 135: 11-19, 1997.
27. Culig Z, Hobisch A, Cronauer MV, Radmayr C, Hittmair A, Zhang J, Thurnher M, Bartsch G and Klocker H: Regulation of prostatic growth and function by peptide growth factors. Prostate 28: 392-405, 1996.
28. Cunha GR: Role of mesenchymal-epithelial interaction in normal and abnormal development of the mammary gland and prostate. Cancer 74: 1030-1044, 1994.
29. Cohen P, Peehl DM, Lamson G and Rosenfeld RG: Insulin-like growth factors (IGFs), IGF receptors and IGF-binding proteins in primary cultures of prostate epithelial cells. J Clin Endocrinol Metab 73: 401-407, 1991.
30. Pietrzkowski Z, Mulholland G, Gomella L, Jameson BA, Wernicke D and Baserga R: Inhibition of growth of prostate cancer cell lines by peptide analogues of insulin-like growth factor I. Cancer Res 53: 1102-1106, 1993.
31. Iwamura M, Sluss PM, Casamento JB and Cockett AT: Insulin-like growth factor-I: action and receptor characterization in human prostate cancer cell lines. Prostate 22: 243-252, 1993.
32. Happerfield LC, Miles DW, Barnes DM, Thomsen LL, Smith P and Hanby A: The localization of the insulin-like growth factor receptor 1 (IGFR-1) in benign and malignant breast tissue. J Pathol 183: 412-417, 1997.
33. Lee AV, Hilsenbeck SG and Yee D: IGF system components as prognostic markers in breast cancer. Breast Cancer Res Treat 47: 295-302, 1998.
34. Baserga R: The IGF-I receptor in cancer research. Experimental Cell Res 253: 1-6, 1999.
35. Christofori G, Naik P and Hanahan DA: A second signal supplied by insulin-like growth factor II in oncogene-induced tumorigenesis. Nature 369: 414-418, 1994.
36. Schirmacher P, Held WA, Yang D, Chisari FV, Rustum Y and Rogler CE: Reaction of insulin-like growth factor II during hepatocarcinogenesis in transgenic mice suggests a role in malignant growth. Cancer Res 52: 2549-2556, 1992.
37. Toretsky JA and Helman IJ: Involvement of IGF-II in human cancer. J Endocrinol 149: 367-372, 1996.